Key result
A 22-year-old woman with pulmonary arterial hypertension associated with congenital heart disease successfully delivered at 36 weeks' gestation following multidisciplinary management with sildenafil and iloprost.
Why the study?
Pregnancy in patients with pulmonary arterial hypertension associated with congenital heart disease carries a high risk of maternal mortality, presenting clinical challenges regarding counselling, contraception, and pregnancy management.
Case Report (n=1)
No
While pregnancy in pulmonary arterial hypertension is high-risk and generally contraindicated, this case illustrates that successful outcomes are possible with careful multidisciplinary management, medication adjustment, and planned delivery.
Case experience advises extreme caution for pregnancy in PAH-CHD; leaves open need for prospective data to guide care.
Background Pregnancy in patients with pulmonary arterial hypertension associated with congenital heart disease is associated with a high risk of maternal mortality. Case presentation An illustrative case study based on experience gained from management of patients through pregnancy is discussed. A 22-year-old female with a history of a closed patent ductus arteriosus in childhood had been diagnosed with significant pulmonary arterial hypertension at the age of 19. Her clinical condition had improved following the commencement of oral combination therapy with sildenafil 25 mg three times daily and macitentan 10 mg once daily. How should she be counselled regarding the risks of pregnancy and what are the most appropriate forms of contraception? What should the approach be if, despite adequate counselling, she subsequently becomes pregnant? Data to help guide decision-making are reviewed and a clinical approach is suggested. Conclusions Patients with pulmonary arterial hypertension should be advised against pregnancy and be given good contraceptive advice. If a patient with pulmonary arterial hypertension becomes pregnant and, after being fully counselled, chooses to proceed with their pregnancy, then they should be managed by an experienced multidisciplinary team.
No takes yet. Share an insight, caveat, or question.
Robin Condliffe (2020) conducted a case report in Pulmonary arterial hypertension associated with congenital heart disease (n=1). Multidisciplinary pregnancy management (sildenafil, iloprost, LMWH) was evaluated on Maternal outcome. A 22-year-old woman with pulmonary arterial hypertension associated with congenital heart disease successfully delivered at 36 weeks' gestation following multidisciplinary management with sildenafil and iloprost.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: